Long term outcome of treating schizophrenia: Antipsychotics probably help - But we badly need more long term studies

British Medical Journal

Volumn 329, Issue 7474, 2004, Pages 1058-1059

  Turner, Trevor Howard ^a  

^a EAST LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOZAPINE; HALOPERIDOL; NEUROLEPTIC AGENT; OLANZAPINE; QUETIAPINE; RISPERIDONE;

DRUG EFFICACY; DRUG MECHANISM; EDITORIAL; EDUCATION; FAMILY; HUMAN; HYPERPROLACTINEMIA; PARKINSONISM; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOPHARMACOTHERAPY; RELAPSE; SCHIZOPHRENIA; SOCIAL SUPPORT; TREATMENT OUTCOME;

ANTIPSYCHOTIC AGENTS; HUMANS; SCHIZOPHRENIA; TREATMENT OUTCOME;

EID: 8544243473     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (12)

1. Nadeem Z, McIntosh A, Lawrie S. EBMH notebook: schizophrenia. Evidence-Based Mental Health 2004;7:2-3.
2. National Institute for Clinical Excellence, Schizophrenia. Core interventions in the treatment and management of schizophrenia in primary and secondary care. Clinical Guidelines 1. London: NICE, 2002.
3. Adams CE, Fenton M, Quraishi S, David AS. Systematic meta-review of depot antipsychotic drugs for people with schizophrenia. Br J Psychiatry 2001;179:290-9.
4. Hegarty JD, Baldessarini RJ, Tohen M, Waternaux C, Oepen G. One hundred years of schizophrenia: a meta-analysis of the outcome literature. Am J Psychiatry 1994;151:409-16.
5. Camprubi M, Dratcu L. Evidence-based management of schizophrenia. Hospital Med 2004;65:201-5.
6. Mason P, Harrison G, Glazebrook C, Medley I, Dalkin T, Croudace T. Characteristics of outcome in schizophrenia at 13 years. Br J Psychiatry 1995;67:596-603.
7. Healy D. Some continuities and discontinuities in the pharmacotherapy of nervous conditions before and after chlorpromazine and imipramine. Hist Psychiatry 2000;11:393-412.
8. Whitaker R. The case against antipsychotic drugs: a 50 year record of doing more harm than good. Med Hypotheses 2004;62:5-13.
9. Chovinand G, Jones B, Annable L. Neuroleptic-induced supersensitivity psychosis. Am J Psychiatry 1978;35;1409-10.
10. Leff J, Sartorius N, Korten A, Ernberg G. The international pilot study of schizophrenia: five-year follow-up findings. Psychol Med 1992;22:131-45.
11. Harrison G, Hopper K, Craig T, Laska E, Siegel C, Wanderung J, et al. Recovery from psychotic illness: a 15 and 25 year international follow-up study. Br J Psychiatry 2001;178:506-17.
12. Which atypical antipsychotic for schizophrenia? Drug Ther Bull 2004;42:57-60.